메뉴 건너뛰기




Volumn 37, Issue 7, 2006, Pages 687-692

Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation

Author keywords

Chronic myelogenous leukemia; Folic acid; Hematopoietic cell transplantation; Methotrexate

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOLIC ACID; METHOTREXATE;

EID: 33645238415     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705303     Document Type: Article
Times cited : (16)

References (29)
  • 1
    • 0022885040 scopus 로고
    • Folic acid supplements in vitamin tablets: A determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia
    • Schroder H, Clausen N, Ostergard E, Pressler T. Folic acid supplements in vitamin tablets: A determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1986; 3: 241-247.
    • (1986) Pediatr Hematol Oncol , vol.3 , pp. 241-247
    • Schroder, H.1    Clausen, N.2    Ostergard, E.3    Pressler, T.4
  • 2
    • 33644820849 scopus 로고    scopus 로고
    • Folate during antifolate chemotherapy: What we know... and do not know
    • Robien K. Folate during antifolate chemotherapy: What we know... and do not know. Nutr Clin Pract 2005; 20: 411-422.
    • (2005) Nutr Clin Pract , vol.20 , pp. 411-422
    • Robien, K.1
  • 3
    • 0000368215 scopus 로고    scopus 로고
    • Antifolates
    • Chabner BA, Longo DL (eds). 2nd edn. Lippincott-Raven Publishers Philadelphia
    • Chu E, Allegra CJ. Antifolates. In: Chabner BA, Longo DL (eds). Cancer Chemotherapy and Biotherapy, 2nd edn. Lippincott-Raven Publishers: Philadelphia, 1996, pp 109-148.
    • (1996) Cancer Chemotherapy and Biotherapy , pp. 109-148
    • Chu, E.1    Allegra, C.J.2
  • 4
    • 0001531566 scopus 로고    scopus 로고
    • Oral complications
    • Thomas ED, Blume KG, Forman SJ (eds). 2nd edn. Blackwell Science Inc. Malden, MA
    • Schubert MM, Peterson DE, Lloid ME. Oral complications. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science Inc. Malden, MA, 1999, pp 751-763.
    • (1999) Hematopoietic Cell Transplantation , pp. 751-763
    • Schubert, M.M.1    Peterson, D.E.2    Lloid, M.E.3
  • 5
    • 20244362642 scopus 로고    scopus 로고
    • Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens
    • Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L et al. Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant 2005; 11: 383-388.
    • (2005) Biol Blood Marrow Transplant , vol.11 , pp. 383-388
    • Cutler, C.1    Li, S.2    Kim, H.T.3    Laglenne, P.4    Szeto, K.C.5    Hoffmeister, L.6
  • 6
    • 0030822786 scopus 로고    scopus 로고
    • Shortage of intravenous multi-vitamin solution in the United States
    • author reply -5
    • Alloju M, Ehrinpreis MN. Shortage of intravenous multi-vitamin solution in the United States. N Engl J Med 1997; 337: 54; author reply -5.
    • (1997) N Engl J Med , vol.337 , pp. 54
    • Alloju, M.1    Ehrinpreis, M.N.2
  • 7
    • 0027980844 scopus 로고
    • Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
    • Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E et al. Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036-2043.
    • (1994) Blood , vol.84 , pp. 2036-2043
    • Clift, R.A.1    Buckner, C.D.2    Thomas, E.D.3    Bensinger, W.I.4    Bowden, R.5    Bryant, E.6
  • 9
    • 0022624255 scopus 로고
    • Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia
    • Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735.
    • (1986) N Engl J Med , vol.314 , pp. 729-735
    • Storb, R.1    Deeg, H.J.2    Whitehead, J.3    Appelbaum, F.4    Beatty, P.5    Bensinger, W.6
  • 10
  • 11
    • 0027275165 scopus 로고
    • A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients
    • Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993; 72: 1612-1617.
    • (1993) Cancer , vol.72 , pp. 1612-1617
    • Woo, S.B.1    Sonis, S.T.2    Monopoli, M.M.3    Sonis, A.L.4
  • 12
    • 0026554876 scopus 로고
    • Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index
    • Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992; 69: 2469-2477.
    • (1992) Cancer , vol.69 , pp. 2469-2477
    • Schubert, M.M.1    Williams, B.E.2    Lloid, M.E.3    Donaldson, G.4    Chapko, M.K.5
  • 13
    • 0028946866 scopus 로고
    • Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients
    • Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 85: 2632-2638.
    • (1995) Blood , vol.85 , pp. 2632-2638
    • Radich, J.P.1    Gehly, G.2    Gooley, T.3    Bryant, E.4    Clift, R.A.5    Collins, S.6
  • 15
    • 0035412398 scopus 로고    scopus 로고
    • Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism
    • Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J et al. Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001; 98: 231-234.
    • (2001) Blood , vol.98 , pp. 231-234
    • Ulrich, C.M.1    Yasui, Y.2    Storb, R.3    Schubert, M.M.4    Wagner, J.L.5    Bigler, J.6
  • 16
    • 2142820811 scopus 로고    scopus 로고
    • Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia
    • Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 2004; 22: 1268-1275.
    • (2004) J Clin Oncol , vol.22 , pp. 1268-1275
    • Robien, K.1    Schubert, M.M.2    Bruemmer, B.3    Lloid, M.E.4    Potter, J.D.5    Ulrich, C.M.6
  • 17
    • 9344266353 scopus 로고    scopus 로고
    • Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia
    • Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B et al. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 2004; 10: 7592-7598.
    • (2004) Clin Cancer Res , vol.10 , pp. 7592-7598
    • Robien, K.1    Ulrich, C.M.2    Bigler, J.3    Yasui, Y.4    Gooley, T.5    Bruemmer, B.6
  • 18
    • 0009244929 scopus 로고
    • The effect of reduced derivatives of folic acid on toxicity and antileukemic effect of methotrexate in mice
    • JC K
    • Mead JAR, Venditti JM, Schrecker AW, Goldin A, JC K. The effect of reduced derivatives of folic acid on toxicity and antileukemic effect of methotrexate in mice. Biochem Pharmacol 1963; 12: 371-383.
    • (1963) Biochem Pharmacol , vol.12 , pp. 371-383
    • Mead, J.A.R.1    Venditti, J.M.2    Schrecker, A.W.3    Goldin, A.4
  • 19
    • 0021366007 scopus 로고
    • Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388
    • Parchure M, Ambaye RY, Gokhale SV. Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388. Chemotherapy 1984; 30: 119-124.
    • (1984) Chemotherapy , vol.30 , pp. 119-124
    • Parchure, M.1    Ambaye, R.Y.2    Gokhale, S.V.3
  • 20
    • 0028593942 scopus 로고
    • Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial
    • Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994; 121: 833-841.
    • (1994) Ann Intern Med , vol.121 , pp. 833-841
    • Morgan, S.L.1    Baggott, J.E.2    Vaughn, W.H.3    Austin, J.S.4    Veitch, T.A.5    Lee, J.Y.6
  • 21
    • 0034944211 scopus 로고    scopus 로고
    • Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicenter, randomized, double-blind, placebo-controlled study
    • van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001; 44: 1515-1524.
    • (2001) Arthritis Rheum , vol.44 , pp. 1515-1524
    • van Ede, A.E.1    Laan, R.F.2    Rood, M.J.3    Huizinga, T.W.4    van de Laar, M.A.5    van Denderen, C.J.6
  • 22
    • 84921431104 scopus 로고    scopus 로고
    • Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
    • CD000951
    • Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2000; 2: CD000951.
    • (2000) Cochrane Database Syst Rev , vol.2
    • Ortiz, Z.1    Shea, B.2    Suarez Almazor, M.3    Moher, D.4    Wells, G.5    Tugwell, P.6
  • 23
    • 1542359519 scopus 로고    scopus 로고
    • Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review
    • Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review. Rheumatology (Oxford) 2004; 43: 267-271.
    • (2004) Rheumatology (Oxford) , vol.43 , pp. 267-271
    • Whittle, S.L.1    Hughes, R.A.2
  • 24
    • 0035018652 scopus 로고    scopus 로고
    • Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines
    • Endresen GK, Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol 2001; 30: 129-134.
    • (2001) Scand J Rheumatol , vol.30 , pp. 129-134
    • Endresen, G.K.1    Husby, G.2
  • 25
    • 0012040815 scopus 로고    scopus 로고
    • Parenteral multivitamin products; drugs for human use; drug efficacy study implementation; amendment
    • Food and Drug Administration, US Department of Health and Human Services
    • Food and Drug Administration, US Department of Health and Human Services. Parenteral multivitamin products; drugs for human use; drug efficacy study implementation; amendment. Federal Register 2000; 65: 21200-21201.
    • (2000) Federal Register , vol.65 , pp. 21200-21201
  • 26
    • 10744219945 scopus 로고    scopus 로고
    • Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer
    • Bajetta E, Celio L, Buzzoni R, Ferrari L, Marchiano A, Martinetti A et al. Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer. Ann Oncol 2003; 14: 1543-1548.
    • (2003) Ann Oncol , vol.14 , pp. 1543-1548
    • Bajetta, E.1    Celio, L.2    Buzzoni, R.3    Ferrari, L.4    Marchiano, A.5    Martinetti, A.6
  • 27
    • 0037842139 scopus 로고    scopus 로고
    • Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma
    • Scagliotti GV, Shin DM, Kindler HL, Vasconcelles MJ, Keppler U, Manegold C et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 2003; 21: 1556-1561.
    • (2003) J Clin Oncol , vol.21 , pp. 1556-1561
    • Scagliotti, G.V.1    Shin, D.M.2    Kindler, H.L.3    Vasconcelles, M.J.4    Keppler, U.5    Manegold, C.6
  • 28
    • 85047688457 scopus 로고    scopus 로고
    • Pemetrexed (Alimta): A novel multitargeted anti-folate agent
    • Adjei AA. Pemetrexed (Alimta): A novel multitargeted anti-folate agent. Expert Rev Anticancer Ther 2003; 3: 145-156.
    • (2003) Expert Rev Anticancer Ther , vol.3 , pp. 145-156
    • Adjei, A.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.